The 20 Best Large-Cell Lung Carcinoma Doctors Near Me in Santa Rosa, CA

To provide state of the art medical care for our patients in a friendly, and compassionate setting. Dr. Shirinian is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 70 other conditions, according to our data. His clinical expertise encompasses Acute Erythroid Leukemia (AEL), Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Shirinian is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Shirinian is currently accepting new patients.

Vijay Suhag is a Hematologist practicing medicine in Roseville, California. Dr. Suhag is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Suhag is board certified in Hematology - Board Certified and Medical Oncology - Board Certified. Dr. Suhag is currently accepting new patients.

Sivakumar Reddy is a Hematologist practicing medicine in Roseville, California. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 75 other conditions, according to our data. His clinical expertise encompasses Gastrointestinal Stromal Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Reddy is board certified in Hematology Medical Oncology. Dr. Reddy is currently accepting new patients.

Caring, compassionate, and patient centric care. Dr. Quock is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Quock is board certified in Internal Medicine and Internal Medicine (Sub: Medical Oncology). Dr. Quock is currently accepting new patients.

David Park is a Hematologist Oncology provider practicing medicine in Fullerton, California. Dr. Park is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Non-Hodgkin Lymphoma, Neuroendocrine Tumor, and Pleuropulmonary Blastoma. Dr. Park is currently accepting new patients.

Joel Neal is an Oncologist practicing medicine in Palo Alto, California. Dr. Neal is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Thymic Epithelial Tumor, and Tissue Biopsy.

Nathan Pennell is a Radiation Oncologist practicing medicine in San Marcos, California. Dr. Pennell is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Thyroidectomy.

Dr. Matthew Gubens is a thoracic oncologist who cares for patients with lung cancer. He specializes particularly in treating non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and mesothelioma. In his research, Gubens studies new treatment strategies for lung cancer and other malignancies of the chest area. Gubens earned his medical degree at Stanford University School of Medicine. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Stanford. He also earned a master's degree in health policy and management at the Harvard T.H. Chan School of Public Health. Gubens is a member of the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and International Thymic Malignancy Interest Group. Dr. Gubens is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Lung Adenocarcinoma. Dr. Gubens is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gubens is currently accepting new patients.

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments. Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF. Dr. Blakely is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Blakely is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Blakely is currently accepting new patients.

Dr. Misako Nagasaka is a board-certified UCI Health oncologist who specializes in the diagnosis and treatment of lung and thyroid cancers. Her clinical interests also early-phase clinical trials, medical ethics and survivorship care for patients.She received her medical degree as well as a PhD from St. Marianna University School of Medicine in Kawasaki, Japan. She completed a residency in internal medicine at Mount Sinai Beth Israel Hospital in New York City, followed by a fellowship in hematology and oncology at Wayne State University School of Medicine's Karmanos Cancer Institute in Detroit, Mich.Her research interests include molecular targeted therapy for lung cancer, immunotherapy and ways to improve patient outcomes. Prior to joining UCI Health, she served as an assistant professor and researcher at Wayne State and the Karmanos institute, she was the principal site investigator on more than 20 lung cancer studies.Nagasaka, who is fluent in Japanese, sees patients at the UCI HealthChao Family Comprehensive Cancer Center in Orange. Dr. Nagasaka is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Gastrostomy. Dr. Nagasaka is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Dr. Victoria Meucci Villaflor is a board-certified UCI Health medical oncologist who specializes in cancers of the head and neck.She earned her medical degree from Rush Medical College of Rush University Medical Center in Chicago. She completed a residency in internal medicine, followed by a fellowship in hematology and medical oncology, both at Rush University Medical Center.Villaflor focuses on improving outcomes for patients through innovative, multidisciplinary care. Her clinical and research interests center on the integration of immune and targeted therapies in both the metastatic and curative-intent settings. She is particularly focused on enhancing the effectiveness and tolerability of systemic therapies in combination with surgery and/or chemoradiation aiming to personalize treatment approaches and improve long term survival and quality of life.A recognized leader in her field, Villaflor has been honored with the Cardinal Bernardin Humanitarian award and was named a top doctor in Southern California and Chicago. She is a dedicated patient advocate associated with Imerman Angels and Gilda's Club Chicago. Her commitment to research, clinical excellence and compassionate care continue to drive her efforts. Dr. Villaflor is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Salivary Gland Tumors, Gastrostomy, and Tissue Biopsy. Dr. Villaflor is board certified in American Board Of Internal Medicine - Medical Oncology.

Dr. Inga Lennes is a medical oncologist who cares for patients with lung cancer. She specializes in managing lung conditions, such as pulmonary nodules, and is an expert in lung screening. After earning her medical degree at the University of Massachusetts Chan Medical School, Lennes completed a residency in internal medicine at Beth Israel Deaconess Medical Center, where she served as chief resident. She completed a fellowship in hematology-oncology at Dana-Farber Brigham Cancer Center. She also has a master of public health degree from the Harvard T.H. Chan School of Public Health and a master of business administration degree from the Massachusetts Institute of Technology. She serves as president of the UCSF Faculty Practice Organization and senior vice president of ambulatory services at UCSF. Dr. Lennes is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, EGFR Positive Lung Cancer, Lung Nodules, and Non-Small Cell Lung Cancer (NSCLC). Dr. Lennes is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Lennes is currently accepting new patients.

Edward Garon is an Oncologist practicing medicine in Santa Monica, California. Dr. Garon is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Karen Reckamp is a Hematologist practicing medicine in Los Angeles, California. Dr. Reckamp is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Tissue Biopsy, and Gastrostomy.

Dr. Michael L. Cheng is a medical oncologist who cares for patients with lung cancer and other tumors affecting the chest, with a particular focus on non-small cell lung cancer. He strives to provide individualized, compassionate care through precision oncology (using the genetic profile of the patient's cancer to custom-tailor treatment). Cheng leads research centered on developing innovative, next-generation treatments for lung cancer, including therapeutic clinical trials with new targeted therapies and immunotherapies. He is inspired by how research discoveries can lead to tangible benefits for patients. Cheng earned his medical degree from the David Geffen School of Medicine at UCLA. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center. Before joining the UCSF faculty, he served as an assistant professor at the Dana-Farber Cancer Institute and Harvard Medical School. Cheng is a member of the American Society of Clinical Oncology (ASCO) and International Association for the Study of Lung Cancer. He has received the Career Development Award from Conquer Cancer, the ASCO Foundation, as well as research funding from the National Institutes of Health and National Cancer Institute. Dr. Cheng is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Large-Cell Lung Carcinoma, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Cheng is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Cheng is currently accepting new patients.

Dr. Miguel A. Villalona-Calero is a UCI Health medical oncologist who specializes in lung cancer, early phase clinical trials, the use of genomic-driven therapies and immune system treatments to target cancer.An internationally regarded expert in lung cancer and developmental therapeutics, Villalona-Calero serves as deputy director of the UCI Health Chao Family Comprehensive cancer center. As chief of the UC Irvine School of Medicine's Division of Hematology-Oncology, he leads a faculty of more than 70 hematologists and oncologists, including nationally know specialists in many types of cancer.He earned his medical degree from Universidad Nacional Pedro Henriquez Urena in the Dominican Republic, followed by an internship and internal medicine residency at Kings County Hospital Center and the State University of New York Health Science Center in Brooklyn. He completed fellowships in medical oncology at the University of Minnesota Hospitals & Clinics in Minneapolis and the Roswell Park Cancer Institute in Buffalo, N.Y.He also received fellowship training at the University of Texas’ Institute for Drug Development in San Antonio and in health policy leadership at New York University’s Wagner Graduate School of Public Service in New York City. Before joining UCI Health, he served as director of an early phase therapeutics program at City of Hope in Duarte, Calif.Villalona-Calero is widely known for his work in lung cancer and developmental therapeutics, including the design of more effective anticancer agents. His main area of expertise is in translating laboratory science developments into clinical trials for cancer patients. Most recently, his focus has been on targeting cellular deficiencies in DNA repair and finding new ways to use the immune system to attack cancer cells.The author or co-author of more than 140 peer-reviewed publications, Villalona-Calero has been inducted into the American Association for the Advancement of Science and is a fellow of the American College of Physicians. He has led dozens of clinical trials, including early phase studies funded by the National Cancer Institute (NCI) and the National Institutes of Health (NIH). He currently leads a phase 1 clinical trial for non-small cell lung cancer using enhanced natural killer cells, part of a prestigious NCI and NIH R01 grant for developmental cell therapeutics.Villalona, who is fluent in English and Spanish, sees patients inIrvineandOrange. Dr. Villalona is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Fanconi Anemia, Congenital Aplastic Anemia, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Villalona is board certified in American Board Of Internal Medicine - Medical Oncology.

Tiffany Svahn is an Oncologist practicing medicine in Pleasant Hill, California. Dr. Svahn is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), and Colorectal Cancer.

Dr. Megan E. Daly is a board-certified UCI Health radiation oncologist.She earned her medical degree and completed a residency in radiation oncology at Stanford University School of Medicine. Dr. Daly is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Gastrostomy, and Microvascular Decompression. Dr. Daly is board certified in American Board Of Radiology - Radiation Oncology.

I believe in patient-center service and am dedicated to provide the most up-to-date, high quality of care to patients with cancer, their families and the community I serve. I uphold cancer patients should be empowered with adequate information and support in the decision-making process. Dr. Hung is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Non-Hodgkin Lymphoma, Paget Disease of the Breast, and Small Cell Lung Cancer (SCLC). Dr. Hung is board certified in American Os Bd Internal Medicine (Sub: Hematology) and American Os Bd Internal Medicine (Sub: Oncology). Dr. Hung is currently accepting new patients.

Kanwaldeep Rasila is an Oncologist practicing medicine in Fairfield, California. Dr. Rasila is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 55 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Intraductal Papilloma, and Subacute Combined Degeneration. Dr. Rasila is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Rasila is currently accepting new patients.